Effect of daBIGatran and rivaROXaban on Platelets

• Conditions: I21.1; Acute transmural myocardial infarction of inferior wall

• Registration Number: DRKS00003157
• Lead Sponsor: niversitätsklinikum FreiburgInnere Medizin 3

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-07-13
• Study Completion: 2014-07-24
• Results First Posted: 2015-11-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

first detected AF and OAC with dabigatran or rivaroxaban, informed consent

Exclusion Criteria

difficult venous puncture

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
change (?) of platelet aggregation assessed by light transmittance aggregometry (LTA) before and after medication.

Secondary Outcome Measures

Name	Time	Method
change (?) of platelet function assessed by Multiplate, VerifyNow and platelet biomarkers before and after medication.